Plexus (NASDAQ:PLXS) Stock Rating Lowered by Wall Street Zen

Plexus (NASDAQ:PLXS – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports.

PLXS has been the topic of a number of other reports. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research note on Friday, July 31st. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. KeyCorp raised Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective for the company in a research note on Monday, September 21st. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Needham & Company LLC restated a “buy” rating and issued a $310.00 target price on shares of Plexus in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, Plexus has an average rating of “Buy” and a consensus price target of $276.86.

Check Out Our Latest Research Report on PLXS

Plexus Stock Performance

NASDAQ PLXS opened at $216.98 on Friday. The company has a 50-day simple moving average of $249.62 and a two-hundred day simple moving average of $258.70. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. Plexus has a 12-month low of $132.03 and a 12-month high of $307.06. The firm has a market cap of $5.81 billion, a price-to-earnings ratio of 32.00 and a beta of 0.88.

Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. During the same period last year, the firm earned $1.64 earnings per share. The company’s revenue for the quarter was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, equities analysts forecast that Plexus will post 7.13 EPS for the current year.

Insider Transactions at Plexus

In related news, Director Michael V. Schrock sold 4,000 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the transaction, the director owned 40,329 shares in the company, valued at $11,090,475. The trade was a 9.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the company’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $240.87, for a total value of $120,435.00. Following the transaction, the director directly owned 7,535 shares of the company’s stock, valued at $1,814,955.45. The trade was a 6.22% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 9,000 shares of company stock worth $2,319,260. Company insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus

Institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new stake in Plexus in the second quarter worth $1,311,631,000. Congress Asset Management Co. raised its holdings in Plexus by 204.0% in the third quarter. Congress Asset Management Co. now owns 315,396 shares of the technology company’s stock worth $82,303,000 after buying an additional 211,663 shares during the last quarter. Bank of America Corp DE bought a new position in Plexus in the 2nd quarter valued at approximately $60,281,000. Bank of New York Mellon Corp purchased a new stake in Plexus during the 2nd quarter valued at $55,525,000. Finally, Emerald Advisers LLC bought a new stake in shares of Plexus in the 1st quarter worth $33,729,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Further Reading

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.